KRAS and neoplasm: BRAF-mutated carcinomas were observed with higher tumor grade (G3) than BRAF-wild type carcinomas (43.5% vs 18.0%; P = 0.005), however, this did not differ significantly with KRAS-mutated and -wild type carcinomas.